$529M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | VOR Vor Biopharma Inc | 1.7M | −2.9% | $31M | 5.9% |
| 2 | ABIVAX SA Abivax Sa | 204,314 | — | $27M | 5.1% |
| 3 | VERA Vera Therapeutics Inc | 600,836 | +201.4% | $26M | 4.9% |
| 4 | ZURA Zura Bio Ltd | 4.2M | +0.0% | $25M | 4.7% |
| 5 | ALMS Alumis Inc | 856,061 | +0.0% | $24M | 4.6% |
| 6 | SLGL Sol-Gel Technologies Ltd | 274,363 | +0.0% | $20M | 3.8% |
| 7 | DFTX Definium Therapeutics Inc | 425,000 | — | $20M | 3.8% |
| 8 | ANNX Annexon Inc | 3.5M | +40.0% | $20M | 3.8% |
| 9 | ORKA Oruka Therapeutics Inc | 183,330 | +0.0% | $17M | 3.3% |
| 10 | MLTX Moonlake Immunotherapeutics | 855,813 | +71.2% | $17M | 3.1% |
| 11 | SGMT Sagimet Biosciences Inc | 2.0M | — | $16M | 3.0% |
| 12 | CTNM Contineum Therapeutics Inc | 921,481 | +15.2% | $15M | 2.9% |
| 13 | IMMX Immix Biopharma Inc | 1.3M | +265.0% | $13M | 2.5% |
| 14 | CLYM Climb Bio Inc | 1.0M | −25.0% | $13M | 2.5% |
| 15 | AMLX Amylyx Pharmaceuticals Inc | 700,000 | −60.0% | $13M | 2.4% |
| 16 | NKTR Nektar Therapeutics | 175,000 | −44.7% | $12M | 2.3% |
| 17 | NGNE Neurogene Inc | 352,180 | −29.6% | $11M | 2.1% |
| 18 | LBRX Lb Pharmaceuticals Inc | 317,221 | +5.7% | $10M | 1.9% |
| 19 | IRD Opus Genetics Inc | 2.0M | +507.4% | $8M | 1.5% |
| 20 | EPRX Eupraxia Pharmaceuticals Inc | 1.2M | +0.0% | $8M | 1.5% |
| 21 | DRUG Bright Minds Biosciences Inc | 109,603 | −50.2% | $8M | 1.5% |
| 22 | INFLARX NV Inflarx Nv | 3.0M | — | $7M | 1.3% |
| 23 | RLMD Relmada Therapeutics Inc | 842,106 | +0.0% | $6M | 1.1% |
| 24 | JATT Jatt Ii Acquisition Corp | 500,000 | — | $6M | 1.1% |
| 25 | CGEM Cullinan Therapeutics Inc | 300,000 | +0.0% | $5M | 1.0% |
| 26 | ALT Altimmune Inc | 1.7M | — | $5M | 1.0% |
| 27 | AMAN Amanat Acquisition Corp | 500,000 | — | $5M | 1.0% |
| 28 | RZLT Rezolute Inc | 951,809 | +0.0% | $5M | 0.9% |
| 29 | SLN Silence Therapeutics Plc | 450,000 | −55.9% | $5M | 0.9% |
| 30 | PALI Palisade Bio Inc | 2.3M | −32.9% | $5M | 0.9% |
| 31 | EVMN Evommune Inc | 325,000 | +0.0% | $4M | 0.8% |
| 32 | SCYX Scynexis Inc | 944,292 | — | $4M | 0.7% |
| 33 | ELVN Enliven Therapeutics Inc | 70,000 | — | $4M | 0.7% |
| 34 | HUMA Humacyte Inc | 3.8M | +0.0% | $3M | 0.6% |
| 35 | RNTX Rein Therapeutics Inc | 2.6M | — | $3M | 0.5% |
| 36 | DBVT Dbv Technologies S A | 156,906 | — | $3M | 0.5% |
| 37 | PMN Promis Neurosciences Inc | 86,150 | −76.8% | $1M | 0.2% |